Literature DB >> 17965967

The induction of apoptosis by daunorubicin and idarubicin in human trisomic and diabetic fibroblasts.

Sylwia Dragojew1, Agnieszka Marczak, Janusz Maszewski, Krzysztof Ilnicki, Zofia Jóźwiak.   

Abstract

In this study, we investigated apoptosis induced in human trisomic and diabetic fibroblasts by daunorubicin (DNR) and its derivative, idarubicin (IDA). The cells were incubated with DNR or IDA for 2 h and then cultured in a drug-free medium for a further 2-48 h. The apoptosis in the cultured cell lines was assessed by biochemical analysis. We found that both drugs induced a time dependent loss of mitochondrial membrane potential, and a significant increase in intracellular calcium and caspase-3 activity. Mitochondrial polarization and changes in the level of intracellular calcium were observed during the first 2-6 h after drug treatment. Caspase-3 activation occurred in the late stages of the apoptotic pathway. Our findings also demonstrated that idarubicin was more cytotoxic and more effective than daunorubicin in inducing apoptosis in trisomic and diabetic fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17965967      PMCID: PMC6275653          DOI: 10.2478/s11658-007-0045-7

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  40 in total

1.  Cytotoxicity of daunorubicin in trisomic (+21) human fibroblasts: relation to drug uptake and cell membrane fluidity.

Authors:  M Przybylska; A Koceva-Chyla; B Rózga; Z Józwiak
Journal:  Cell Biol Int       Date:  2001       Impact factor: 3.612

Review 2.  Apoptosis: mechanisms and relevance in cancer.

Authors:  Katrien Vermeulen; Dirk R Van Bockstaele; Zwi N Berneman
Journal:  Ann Hematol       Date:  2005-07-22       Impact factor: 3.673

Review 3.  Reactive oxygen intermediates as mediators of programmed cell death in plants and animals.

Authors:  T Jabs
Journal:  Biochem Pharmacol       Date:  1999-02-01       Impact factor: 5.858

4.  Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines.

Authors:  D Bellarosa; A Ciucci; A Bullo; F Nardelli; S Manzini; C A Maggi; C Goso
Journal:  J Pharmacol Exp Ther       Date:  2001-02       Impact factor: 4.030

5.  Anthracyclines - a review of general and special toxicity studies.

Authors:  G Mazue; M Iatropoulos; A Imondi; S Castellino; M Brughera; A Podesta; P Dellatorre; D Moneta
Journal:  Int J Oncol       Date:  1995-10       Impact factor: 5.650

6.  Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children.

Authors:  U Ozgen; S Savaşan; S Buck; Y Ravindranath
Journal:  Cytometry       Date:  2000-02-15

7.  Regulation of phospholipase D activity and ceramide production in daunorubicin-induced apoptosis in A-431 cells.

Authors:  J S Chen; M Q Chai; H H Chen; S Zhao; J G Song
Journal:  Biochim Biophys Acta       Date:  2000-11-15

8.  GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons.

Authors:  Alejandra Pelsman; Carlos Hoyo-Vadillo; Tatiana A Gudasheva; Sergei B Seredenin; Rita U Ostrovskaya; Jorge Busciglio
Journal:  Int J Dev Neurosci       Date:  2003-05       Impact factor: 2.457

9.  Changes in GSH-antioxidant system induced by daunorubicin in human normal and diabetic fibroblasts.

Authors:  Agnieszka Zatorska; Janusz Maszewski; Zofia Jóźwiak
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

10.  Morphological and biochemical changes in human fibroblast lines induced by anthracyclines during apoptosis.

Authors:  Katarzyna Kania; Sylwia Dragojew; Zofia Jóźwiak
Journal:  Cell Mol Biol Lett       Date:  2003       Impact factor: 5.787

View more
  1 in total

Review 1.  Two drugs are better than one. A short history of combined therapy of ovarian cancer.

Authors:  Barbara Bukowska; Arkadiusz Gajek; Agnieszka Marczak
Journal:  Contemp Oncol (Pozn)       Date:  2014-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.